Medindia

X

Inverness Medical Innovations to Present at the UBS 20th Annual Global Healthcare Services Conference on February 9, 2010

Monday, February 1, 2010 General News J E 4
Advertisement

WALTHAM, Mass., Feb. 1 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (NYSE: IMA), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, announced today that it will attend the UBS 20th Annual Global Healthcare Services Conference being held February 8 through 10, 2010 at the Grand Hyatt New York.  Jon Russell, Vice President, Finance, will attend.  Mr. Russell's presentation is scheduled for Tuesday, February 9, 2010 at 2:30 p.m., and will be made available to the public through a webcast accessible via http://cc.talkpoint.com/ubsx001/020810a_ke/?entity=49_5W7WXYO as well as through the company's website at http://www.invmed.com/investors.cfm.   A replay of the webcast will be available via the links above for approximately 30 days from the date of the webcast.  During his presentation, Mr. Russell may discuss and answer questions concerning business and financial developments and trends.  His responses to questions, as well as other matters discussed during the webcast, may contain or constitute information that has not been disclosed previously.

By developing new capabilities in near-patient diagnosis, monitoring and health management, Inverness Medical Innovations enables individuals to take charge of improving their health and quality of life.  A global leader in rapid point-of-care diagnostics, Inverness' products, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women's health.  Inverness is headquartered in Waltham, Massachusetts.  

SOURCE Inverness Medical Innovations, Inc.

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Boston Scientific Settles Longstanding Patent Disp...
S
Benlysta Will Garner Sales of More Than $500 Milli...